Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Advances in Therapy|November 4, 2020
Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis CMark Sulkowski, Wei-Han Cheng, Steven Marx, et al.
Infectious Diseases and Therapy|June 17, 2023
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV PatientsNancy Reau, Wei-Han Cheng, Qiujun Shao, et al.
The Annals of Pharmacotherapy|July 25, 2017
Quality of Pharmacist-Managed Anticoagulation Therapy in Long-Term Ambulatory Settings: A Systematic ReviewBeenish S Manzoor, Wei-Han Cheng, James C Lee, et al.
Infectious Diseases and Therapy|December 16, 2021
Awareness and Epidemiology of Chronic Hepatitis C Virus Infections in FloridaEmmanuel Thomas, Wei-Han Cheng, Douglas E Dylla, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 9, 2025
Burden of disease and unmet clinical needs in pediatric patients with asthma: real-world experience from the United States and five European countriesWei-Han Cheng, Kinga Borsos, Zhixiao Wang, et al.
Advances in Therapy|June 7, 2023
Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World StudyAnthony Martinez, Wei-Han Cheng, Steven E Marx, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2026
Long-term efficacy of dupilumab versus tezepelumab in asthma: a matching-adjusted indirect comparisonKenneth R Chapman, Nick Freemantle, Patricia Guyot, et al.
Cancer Medicine|August 12, 2023
Post-remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre- versus post-VIALE-A real-world experience from a predominantly US community settingPankit Vachhani, Esprit Ma, Tao Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2023
Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community SettingAnda Gershon, Esprit Ma, Tao Xu, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 23, 2023
Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs)Amer M Zeidan, Elizabeth S Mearns, Carmen D Ng, et al.
Pageof 3